Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 18, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Veracyte, Inc.
| -7.50K |
$25.00 | -$187,500.00 | -18.41% | 33.23K |
Jul 16
|
Scheduled
| ||||||
Veracyte, Inc.
| -1.28K |
$25.00 | -$31,925.00 | -1.52% | 82.97K |
Jul 16
|
Scheduled
| ||||||
Veracyte, Inc.
| -5.00K |
$24.50 | -$122,500.00 | -13.20% | 32.88K |
Jul 16
|
Scheduled
| ||||||
Veracyte, Inc.
| 11.47K |
—
|
—
| +30.51% | 49.07K |
Jun 13
| |||||||
Veracyte, Inc.
| 11.47K |
—
|
—
| +37.75% | 41.87K |
Jun 13
| |||||||
Veracyte, Inc.
| 11.47K |
—
|
—
| +43.45% | 37.88K |
Jun 13
| |||||||
Veracyte, Inc.
| 11.47K |
—
|
—
| +49.66% | 34.58K |
Jun 13
| |||||||
Veracyte, Inc.
| 11.47K |
—
|
—
| +34.64% | 44.6K |
Jun 13
| |||||||
Veracyte, Inc.
| 11.47K |
—
|
—
| +39.22% | 40.73K |
Jun 13
| |||||||
Veracyte, Inc.
| -3.87K |
$20.59 | -$79,683.30 | -11.68% | 29.25K |
Jun 11
|
Scheduled
| ||||||
Veracyte, Inc.
| -3.87K |
$20.32 | -$78,633.76 | -14.35% | 23.11K |
Jun 10
|
Scheduled
| ||||||
Veracyte, Inc.
|
0
|
$15.69 | -$26,400.00 |
—
| 33.13K |
Jun 7
|
Scheduled
| ||||||
Veracyte, Inc.
| -3.46K |
$20.75 | -$71,836.50 | -2.36% | 143.24K |
Jun 2
| |||||||
Veracyte, Inc.
| -1.92K |
$20.75 | -$39,819.25 | -1.97% | 95.41K | +1 |
Jun 2
| ||||||
Veracyte, Inc.
| -5.75K |
$20.75 | -$119,229.50 | -1.74% | 323.99K |
Jun 2
| |||||||
Veracyte, Inc.
| -1.31K |
$20.75 | -$27,265.50 | -1.54% | 84.25K |
Jun 2
| |||||||
Veracyte, Inc.
| -1.09K |
$20.75 | -$22,555.25 | -2.22% | 47.97K | +1 |
Jun 2
| ||||||
Veracyte, Inc.
| -1.54K |
$21.00 | -$32,319.00 | -5.40% | 26.98K |
May 28
|
Scheduled
| ||||||
Veracyte, Inc.
|
0
|
$17.42 | -$84,628.00 |
—
| 33.13K |
Apr 1
| |||||||
Veracyte, Inc.
| 2.13K |
$21.10 | -$46,187.90 | +1.47% | 146.7K |
Mar 15
| |||||||
Veracyte, Inc.
| 5.81K |
$21.10 | -$125,988.10 | +1.79% | 329.74K |
Mar 15
| |||||||
Veracyte, Inc.
| 114.72K |
—
|
—
| +54.84% | 323.93K |
Mar 6
| |||||||
Veracyte, Inc.
| 49.88K |
—
|
—
| +139.80% | 85.56K |
Mar 6
| |||||||
Veracyte, Inc.
| 49.88K |
—
|
—
| +105.13% | 97.33K | +1 |
Mar 6
| ||||||
Veracyte, Inc.
| 23.94K |
—
|
—
| +95.33% | 49.06K | +1 |
Mar 6
| ||||||
Veracyte, Inc.
| 59.86K |
—
|
—
| +70.65% | 144.57K |
Mar 6
| |||||||
Veracyte, Inc.
| 39.9K |
—
|
—
| +75.03% | 93.09K |
Mar 6
| |||||||
Veracyte, Inc.
| -4.35K |
$24.00 | -$104,328.00 | -8.39% | 47.45K | +1 |
Mar 2
| ||||||
Veracyte, Inc.
| -2.34K |
$24.00 | -$56,088.00 | -8.51% | 25.12K | +1 |
Mar 2
| ||||||
Veracyte, Inc.
|
0
|
$18.77 | -$111,699.00 |
—
| 37.6K |
Mar 1
| |||||||
Veracyte, Inc.
| -6.11K |
$24.00 | -$146,688.00 | -6.73% | 84.72K |
Mar 2
| |||||||
Veracyte, Inc.
| -3.01K |
$24.00 | -$72,192.00 | -7.78% | 35.68K |
Mar 2
| |||||||
Veracyte, Inc.
| -13.29K |
$24.00 | -$318,864.00 | -5.97% | 209.21K |
Mar 2
| |||||||
Veracyte, Inc.
| -803.00 |
$26.54 | -$21,311.62 | -1.53% | 51.79K | +1 |
Dec 2
| ||||||
Veracyte, Inc.
| -507.00 |
$26.54 | -$13,455.78 | -1.84% | 27.02K | +1 |
Dec 2
| ||||||
Veracyte, Inc.
| -3.20K |
$26.54 | -$85,007.62 | -1.42% | 221.88K |
Dec 2
| |||||||
Veracyte, Inc.
| -556.00 |
$26.54 | -$14,756.24 | -1.42% | 38.69K |
Dec 2
| |||||||
Veracyte, Inc.
| -1.80K |
$26.54 | -$47,772.00 | -1.94% | 90.83K |
Dec 2
| |||||||
Veracyte, Inc.
| 53.18K |
—
|
—
|
∞
| 53.18K |
Oct 2
| |||||||
Veracyte, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.